ASX:MSB

Mesoblast Limited Stock Predictions

Australian Securities Exchange > Healthcare > Biotechnology

Open Broker Account

$1.07

-0.0250 (-2.29%)

At Close: May 10, 2024

Currently predicting for Mon, 13 May 2024

Trading levels for MSB.AX

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	1.16	8.45 %
		R2	1.13	5.76 %
		R1	1.11	4.10 %
Current price:			1.07
	Support	S1	1.05	-1.28 %
		S2	1.03	-2.94 %
		S3	1.01	-5.63 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	1.16	8.45 %
		R2	1.09	1.88 %
		R1	1.07	0.469 %
Current price			1.07
	Support	S1	0.95	-10.80%
		S2	0.90	-15.49%
		S3	0.89	-16.90%

MSB.AX Predictions History

1 week ago
con predicted that MSB.AX for May. 2nd is going

Rank:

About Mesoblast Limited

Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchyma... MSB.AX Profile

Golden Star

Ticker	Date	Change	Price
SXI	May 08	2.97%	$173.34
NVO	May 08	1.37%	$126.69
PAG	May 07	1.42%	$153.22
WMT	May 06	1.02%	$59.87
UNP	May 06	3.42%	$239.21
JPM	May 06	3.53%	$192.00
INGR	May 03	4.94%	$114.56
ASH	May 03	2.28%	$95.85
INVH	May 03	1.13%	$34.39
INTU	May 03	0.483%	$629.27

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In